Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome

CONTEXT: Recombinant human GH (rhGH) therapy in Prader-Willi syndrome (PWS) has been used by the medical community and advocated by parental support groups since its approval in the United States in 2000 and in Europe in 2001. Its use in PWS represents a unique therapeutic challenge that includes tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Deal, Cheri L., Tony, Michèle, Höybye, Charlotte, Allen, David B., Tauber, Maïthé, Christiansen, Jens Sandahl, Ambler, Geoffrey R., Battista, Renaldo, Beauloye, Véronique, Berall, Glenn, Biller, Beverly M. K., Butler, Merlin G., Cassidy, Suzanne B., Chihara, Kazuo, Cohen, Pinchas, Craig, Maria, Farholt, Stense, Goetghebeur, Mireille, Goldstone, Anthony P., Greggi, Tiziana, Grugni, Graziano, Hokken-Koelega, Anita C., Johannsson, Gudmundur, Johnson, Keegan, Kemper, Alex, Kopchick, John J., Malozowski, Saul, Miller, Jennifer, Mogul, Harriette R., Muscatelli, Françoise, Nergårdh, Ricard, Nicholls, Robert D., Radovick, Sally, Rosenthal, M. Sara, Sipilä, Ilkka, Tarride, Jean-Eric, Vogels, Annick, Waters, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2013
Materias:
JCEM Online: Advances in Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789886/
https://www.ncbi.nlm.nih.gov/pubmed/23543664
http://dx.doi.org/10.1210/jc.2012-3888

Ejemplares similares

Ejemplares similares